Florida Hospital Cancer Institute, Orlando, is conducting a clinical trial for women who have completed treatment for ovarian, fallopian tube or primary peritoneal cancer.
“This is the first large-scale nationwide ovarian cancer trial to focus on the effects of diet and exercise on preventing or delaying disease recurrence for patients that have completed their therapy and are currently in remission,” James Kendrick, MD, gynecologic oncologist and principal investigator on the study, said in a news release. “Studies suggest diet and exercise may improve survival for breast cancer patients, but no thorough studies for ovarian cancer have been done to determine if this is true for a disease that frequently recurs and has an extremely high mortality rate.”
The 1,070 women in the national clinical trial will be asked to make diet and exercise changes for 24 months of the seven-year study. If eligible, women will be randomly chosen for one of two groups, the usual care group or the lifestyle intervention group.
The lifestyle intervention group is asked to increase their level of activity and wear a pedometer to track the number of steps taken in a day. Each individual will be given a target number of steps to take each day. The women in the lifestyle intervention group also will be required to eat specific amounts of fruits, vegetables, fat and fiber per day. The usual care group will not be asked to change their physical or eating habits.
For more information on the clinical trial, call 407-303-2859 or visit FloridaHospitalCancer.com/Clinical-Trials.